California Imposes Controversial Cost-Sharing Restrictions to Facilitate Patient Access to Expensive Drugs

Published date15 December 2015
Law FirmEpstein Becker & Green
AuthorJohn Linehan
Subject MatterCost-Sharing,Drug Pricing,Healthcare,Insurance Industry,Pharmaceutical Industry,Prescription Drugs

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT